Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling
- PMID: 8627172
- PMCID: PMC2192449
- DOI: 10.1084/jem.183.2.611
Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling
Abstract
Zeta-associated protein (ZAP)-70 is a cytoplasmic protein tyrosine required for T cell antigen receptor (TCR) signaling and development. Mutations in ZAP-70 result in severe combined immunodeficiency in humans. ZAP-70 interacts with the TCR by binding to tyrosine-phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) present in the invariant subunits of the TCR complex. Here we report that two ZAP-70 mutants devoid of kinase activity, generated either by a point mutation in the kinase domain to create an inactive kinase, or by truncation of the entire kinase domain (SH2[N+C]), functioned as dominant-negative mutants to specifically suppress TCR-mediated activation of NFAT, a nuclear factor essential for inducible interleukin 2 gene expression. Biochemical studies with the SH2(N+C) mutant showed that it also blocked early TCR signaling events, such as p95vav tyrosine phosphorylation, extracellular signal-regulated kinase 2 activation, and the association of a number of tyrosine-phosphorylated proteins with growth factor receptor-binding protein 2 (GRB2). The inhibitory effects of the SH2(N+C) mutant revealed that it requires an intact phosphotyrosine-binding site in its COOH-terminal SH2 domain. Using a CD8-zeta chimeric receptor to analyze the interaction of the SH2(N+C) mutant with ITAMs of TCR-zeta, we found that this mutant was constitutively bound to the hyperphosphorylated CD8-zeta chimera. These results indicate that tyrosine-phosphorylated ITAM is the target for the action of this dominant-negative mutant, suggesting that the assembly of a functional receptor signaling complex on ITAMs is a critical proximal TCR signaling event leading to downstream activation.
Similar articles
-
TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.J Immunol. 1999 Jul 15;163(2):844-53. J Immunol. 1999. PMID: 10395678
-
ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.J Exp Med. 1995 Jan 1;181(1):375-80. doi: 10.1084/jem.181.1.375. J Exp Med. 1995. PMID: 7528772 Free PMC article.
-
Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation.EMBO J. 1999 Apr 1;18(7):1832-44. doi: 10.1093/emboj/18.7.1832. EMBO J. 1999. PMID: 10202147 Free PMC article.
-
The role of tyrosine kinases and phosphotyrosine-containing recognition motifs in regulation of the T cell-antigen receptor-mediated signal transduction pathway.J Leukoc Biol. 1994 Feb;55(2):265-71. doi: 10.1002/jlb.55.2.265. J Leukoc Biol. 1994. PMID: 7507972 Review.
-
Early activation defects in T lymphocytes from aged mice.Immunol Rev. 1997 Dec;160:79-90. doi: 10.1111/j.1600-065x.1997.tb01029.x. Immunol Rev. 1997. PMID: 9476667 Review.
Cited by
-
Systematic identification of regulatory proteins critical for T-cell activation.J Biol. 2003;2(3):21. doi: 10.1186/1475-4924-2-21. Epub 2003 Sep 15. J Biol. 2003. PMID: 12974981 Free PMC article.
-
Interdomain B in ZAP-70 regulates but is not required for ZAP-70 signaling function in lymphocytes.Mol Cell Biol. 1999 Jan;19(1):948-56. doi: 10.1128/MCB.19.1.948. Mol Cell Biol. 1999. PMID: 9858619 Free PMC article.
-
CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function.Cancer Immunol Res. 2021 Sep;9(9):999-1007. doi: 10.1158/2326-6066.CIR-21-0095. Epub 2021 Jun 30. Cancer Immunol Res. 2021. PMID: 34193461 Free PMC article.
-
Adhesion to fibronectin promotes the activation of the p125(FAK)/Zap-70complex in human T cells.Immunology. 1999 Dec;98(4):564-8. doi: 10.1046/j.1365-2567.1999.00917.x. Immunology. 1999. PMID: 10594689 Free PMC article.
-
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.Blood. 2008 Mar 1;111(5):2685-92. doi: 10.1182/blood-2006-12-062265. Epub 2007 Nov 29. Blood. 2008. PMID: 18048647 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous